Dr. Rongqing Li 李荣清
Oncology · Chief Physician
Radiation Oncology, The First Affiliated Hospital of Kunming Medical University, Kunming
Public profile Compiled from public sources. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Comprehensive treatment of various malignant tumors, including lung cancer, breast cancer, colorectal cancer, and head and neck tumors.
Conditions and procedures: Lung cancer, Breast cancer, Colorectal cancer, Head and neck tumors
From the doctor's own description on a public doctor-listing platform.
Name order: in Chinese the family name comes first (Li Rongqing). Papers usually list the name as Rongqing Li.
Selected publications
8 first- or senior-author papers on PubMed where the author's own affiliation is this hospital (8 since 2016). Most recent:
- Front Mol Biosci, 2026 (senior author): Impact of oxidative stress on malignant tumor progression and emerging therapeutic strategies. PubMed 42698535
- Cancer Rep (Hoboken), 2026 (senior author): Postoperative Adjuvant Chemoradiotherapy ± PD-1 Inhibitor for Locally Advanced Head and Neck Squamous Cell Carcinoma. PubMed 41758071
- Discov Oncol, 2025 (senior author): PEITC restores chemosensitivity in cisplatin-resistant non-small cell lung cancer by targeting c-Myc/miR-424-5p. PubMed 41171377
- Heliyon, 2024 (senior author): TP53 mitigates cisplatin resistance in non-small cell lung cancer by mediating the effects of resistant cell-derived exosome mir-424-5p. PubMed 38439876
- Radiat Oncol, 2022 (senior author): The long-term survival of the doublet regimen of concurrent chemoradiation therapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective study. PubMed 36397078
- Bioengineered, 2022 (senior author): Knockdown of mitochondrial threonyl-tRNA synthetase 2 inhibits lung adenocarcinoma cell proliferation and induces apoptosis. PubMed 35184682
- Tohoku J Exp Med, 2019 (senior author): Fraxetin Suppresses Proliferation of Non-Small-Cell Lung Cancer Cells via Preventing Activation of Signal Transducer and Activator of Transcription 3. PubMed 31080186
- Ultrastruct Pathol, 2017 (senior author): Antitumor activity of the pachymic acid in nasopharyngeal carcinoma cells. PubMed 28414554
Each paper was checked automatically: the author listed with this name must give this hospital as their affiliation. See the full PubMed search.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and recommend a treatment plan.
Get a specialist opinion